From 1st May 2017, high risk Human Papilloma Virus (HPV) will become the Medicare-funded cervical screening test. Conventional Pap smears will not be funded by Medicare (apart from a few special groups) after 1st May 2017. It will still be necessary to obtain a cervical sample which will be placed in a liquid based cytology […]